Richard Fine, United States Summary conclusion: The ICE3 trial suggests that cryoablation with ProSense®, complemented by adjuvant therapy, is a viable alternative to surgical excision for ...

About IceCure Medical IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous ...

An abstract on ICE3 study results by Dr. Richard Fine was accepted and included in the poster presentation gallery An independent study by Dr. Ava Kwong evaluated expanding the ICE3 study ...

Background: Cryoablation (CRYO) is an alternative to radiofrequency (RF) ablation in the treatment of atrioventricular nodal reentrant tachycardia (AVNRT). This study aims to evaluate the ...

About IceCure Medical IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, ...

About IceCure Medical IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the treatment of tumors (benign and cancerous) by freezing ...